Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-07-02
APTOAptose Biosciences Inc.Marango JotinSVP, Chief Bus. OfficerS - Sale$6.34-20,946179,054-10%-$132,793
2020-07-01
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$167.58-11,573163,181-7%-$1,939,352
D
2020-07-01
HARPHarpoon Therapeutics, Inc.Wesche HolgerChief Scientific OfficerS - Sale+OE$16.20-10,00052,669-16%-$161,989
D
2020-07-01
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Business Development OffS - Sale+OE$47.34-6,7710-100%-$320,540
D
2020-07-01
ADPTAdaptive Biotechnologies CorpHill Nancy LouiseEVP, Operations, Program ManaS - Sale+OE$47.42-3,00011,200-21%-$142,266
D
2020-07-01
VIRVir Biotechnology, Inc.Parrish JayChief Business OfficerS - Sale+OE$37.95-75,000222,222-25%-$2,846,310
D
2020-07-01
VIRVir Biotechnology, Inc.Pang PhillipChief Medical OfficerS - Sale+OE$37.78-12,50015,777-44%-$472,252
M
2020-07-01
VIRVir Biotechnology, Inc.Horn HowardCFOS - Sale$38.92-20,000207,777-9%-$778,399
D
2020-06-30
NKNantkwest, Inc.Simon Barry J.See remarksS - Sale+OE$13.00-93,170,5400%-$117
2020-06-30
NSTGNanostring Technologies IncBailey K ThomasCFOS - Sale$29.17-3,2600-100%-$95,105
D
2020-06-30
FUSNFusion Pharmaceuticals Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Former 10% OwnerP - Purchase$17.00+250,0004,853,588+5%+$4,250,000
2020-07-01
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$62.92-18,34424,297,5010%-$1,154,204
D
2020-06-30
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$64.00-39,7520-100%-$2,544,294
2020-07-01
PTEPolarityte, Inc.Seaburg David BCEOS - Sale$1.28-8,5141,002,451-1%-$10,881
2020-06-30
FUSNFusion Pharmaceuticals Inc.Preston HeatherDirP - Purchase$17.00+8,8238,823New+$149,991
2020-06-30
FUSNFusion Pharmaceuticals Inc.O'Leary James JChief Medical OfficerP - Purchase$17.00+300300New+$5,100
2020-06-30
FUSNFusion Pharmaceuticals Inc.Crowley John JCFOP - Purchase$17.00+6,5006,500New+$110,500
D
2020-06-30
FUSNFusion Pharmaceuticals Inc.Khuong Chau QuangDirP - Purchase$17.00+898,000192,100-127%+$15,266,000
D
2020-06-30
FUSNFusion Pharmaceuticals Inc.Healthcap Vii, L.P.10%P - Purchase$17.00+240,0003,807,247+7%+$4,080,000
D
2020-06-30
FUSNFusion Pharmaceuticals Inc.Christenson JohanDirP - Purchase$17.00+240,0003,807,247+7%+$4,080,000
D
2020-06-30
FUSNFusion Pharmaceuticals Inc.Orbimed Advisors LLCDirP - Purchase$17.00+898,0003,122,770+40%+$15,266,000
D
2020-06-30
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale+OE$35.10-6,81261,069-10%-$239,101
D
2020-06-30
MNTAMomenta Pharmaceuticals IncArroyo SantiagoSVP, Chief Medical OfficerS - Sale+OE$35.10-6,81245,538-13%-$239,101
D
2020-06-30
MNTAMomenta Pharmaceuticals IncCieplinska AgnieszkaChief Accounting Officer (PAO)S - Sale+OE$35.11-9477,574-11%-$33,249
D
2020-06-30
MNTAMomenta Pharmaceuticals IncKwon YoungChief Financial, Bus. OfficerS - Sale+OE$35.11-6,810157,936-4%-$239,099
D
2020-06-30
MNTAMomenta Pharmaceuticals IncCarvajal AlejandraGCS - Sale+OE$35.10-6,81127,445-20%-$239,066
D
2020-06-30
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale+OE$35.10-6,81124,123-22%-$239,066
D
2020-06-30
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale+OE$35.10-6,81129,191-19%-$239,066
D
2020-06-30
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$33.32-37,575666,749-5%-$1,251,999
2020-06-30
XFORX4 Pharmaceuticals, IncMostafa Adam S.See RemarksS - Sale$9.04-1,7257,923-18%-$15,594
D
2020-06-26
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Business Development OffS - Sale+OE$47.42-4170-100%-$19,774
2020-06-29
ADAPAdaptimmune Therapeutics PlcWood GavinCFOP - Purchase$1.62+33,00033,000New+$53,460
D
2020-06-26
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Business Development OffS - Sale+OE$47.42-4170-100%-$19,774
M
2020-06-26
DNLIDenali Therapeutics Inc.Bratton Douglas K10%S - Sale$23.97-250,00014,092,916-2%-$5,993,052
2020-06-26
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$60.65-11,04624,315,8450%-$669,892
2020-06-25
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$67.00-10,00024,326,8910%-$670,000
DM
2020-06-26
VXRTVaxart, Inc.Armistice Capital, LLCDirS - Sale+OE$9.67-27,612,053291,046-99%-$266,997,653
2020-06-26
TBIOTranslate Bio, Inc.Baupost Group Llc/ma10%P - Purchase$22.00+500,00018,044,239+3%+$11,000,000
M
2020-06-26
ALLOAllogene Therapeutics, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.10%S - Sale$42.53-85,15119,716,3060%-$3,621,601
2020-06-29
PTEPolarityte, Inc.Hoyler Cameron J.Gen. Counsel, EVPS - Sale$1.44-936622,1840%-$1,348
2020-06-29
NKNantkwest, Inc.Soon-Shiong PatrickCOB, CEO, 10%P - Purchase$12.12+3,710,00069,944,890+6%+$44,965,200
M
2020-05-27
PSTIPluristem Therapeutics IncClover Wolf Capital - Limited Partnership10%P - Purchase$7.61+700,4493,211,760+28%+$5,328,131
2020-06-25
VIRVir Biotechnology, Inc.Horn HowardCFOS - Sale$50.00-30,000227,777-12%-$1,500,000
DM
2020-06-24
CRSPCrispr Therapeutics AGKlein Lawrence OttoCBO, COOS - Sale+OE$75.88-70,00020,000-78%-$5,311,564
2020-06-25
ATRAAtara Biotherapeutics, Inc.Touchon PascalPres, CEOS - Sale$12.92-12,135264,844-4%-$156,784
A
2020-01-03
CDTXCidara Therapeutics, Inc.Abdollahian NeilChief Business OfficerS - Sale$3.42-94050,308-2%-$3,215
A
2020-01-03
CDTXCidara Therapeutics, Inc.Daruwala PaulCOOS - Sale$3.42-94052,592-2%-$3,215
DM
2020-06-23
ADPTAdaptive Biotechnologies CorpRobins Harlan SChief Scientific OfficerS - Sale+OE$46.54-33,300679-98%-$1,549,813
D
2020-06-24
ADPTAdaptive Biotechnologies CorpTaylor Stacy LSVP, GCS - Sale+OE$46.68-2,8801,300-69%-$134,438
DM
2020-06-23
APTOAptose Biosciences Inc.Whitehead WarrenDirS - Sale+OE$6.93-35,00040,000-47%-$242,550
M
2020-06-23
ALLOAllogene Therapeutics, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.10%S - Sale$44.04-219,85319,801,457-1%-$9,682,651
D
2020-06-23
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$63.71-39,7520-100%-$2,532,720
M
2020-06-23
MRNAModerna, Inc.Hoge StephenPresS - Sale$64.24-10,0001,980,656-1%-$642,444
2020-06-24
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$63.25-9,00024,336,8910%-$569,250
2020-06-23
ALECAlector, Inc.McGuire TerranceDir, 10%S - Sale$31.54-4,37712,853,8170%-$138,063
D
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10%P - Purchase$20.00+1,000,0002,252,913+80%+$20,000,000
2020-06-23
ALECAlector, Inc.Polaris Venture Management Co. Vi, L.L.C.10%S - Sale$31.54-4,37712,853,8170%-$138,063
2020-06-24
TCONTracon Pharmaceuticals, Inc.Theuer CharlesPres, CEOP - Purchase$1.90+9,89571,714+16%+$18,801
2020-06-23
CRSPCrispr Therapeutics AGNovak RodgerPresS - Sale$75.00-50,000698,007-7%-$3,750,000
D
2020-06-23
NBIXNeurocrine Biosciences IncRoberts EiryChief Medical OfficerS - Sale+OE$130.00-5,0009,416-35%-$650,000
D
2020-06-23
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$130.00-5,00026,021-16%-$650,000
2020-06-23
GILDGilead Sciences IncRodriguez JavierDirS - Sale$75.50-1890-100%-$14,270
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Wirth PeterDirP - Purchase$0.00+63,299127,665+98%+$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Wirth PeterDirS - Sale$0.00-78,454127,665-38%-$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Kelly Patrick F.Chief Medical OfficerP - Purchase$0.00+42,95942,959New+$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Kelly Patrick F.Chief Medical OfficerS - Sale$0.00-64,28842,959-60%-$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Fanucci MarshaDirP - Purchase$0.00+52,53252,532New+$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Fanucci MarshaDirS - Sale$0.00-67,89452,532-56%-$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Clackson Timothy PDirP - Purchase$0.00+23,59023,590New+$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Clackson Timothy PDirS - Sale$0.00-35,06723,590-60%-$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Wadlinger Mary E.See RemarksP - Purchase$0.00+115,575115,575New+$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Wadlinger Mary E.See RemarksS - Sale$0.00-144,452115,575-56%-$0
D
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Ra Capital Management, L.P.10%P - Purchase$20.00+4,000,0009,011,651+80%+$80,000,000
D
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Kolchinsky PeterDir, 10%P - Purchase$20.00+4,000,0009,011,651+80%+$80,000,000
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Paoletti PaoloDirP - Purchase$0.00+45,55345,553New+$0
2020-06-23
FMTXForma Therapeutics Holdings, Inc.,Paoletti PaoloDirS - Sale$0.00-59,36145,553-57%-$0
DM
2020-06-23
VIRVir Biotechnology, Inc.Virgin HerbertEVP, Research, CSOS - Sale+OE$44.64-14,9200-100%-$666,058
M
2020-06-22
CRSPCrispr Therapeutics AGBolzon Bradley J PhdDirS - Sale$73.93-20,0004,183,0640%-$1,478,522
M
2020-06-22
CRSPCrispr Therapeutics AGHo Tony WEVP, Head of R, DS - Sale$75.04-7,15833,747-17%-$537,123
D
2020-06-22
KODKodiak Sciences Inc.Ehrlich JasonSee RemarksS - Sale+OE$60.54-6,95031,284-18%-$420,747
D
2020-06-22
CHRSCoherus Biosciences, Inc.Szela Mary TDirS - Sale+OE$17.58-54,9970-100%-$966,759
2020-06-22
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$65.92-4,52124,346,8910%-$298,024
D
2020-06-23
VCELVericel CorpHalpin MichaelCOOS - Sale+OE$15.01-14,7511,622-90%-$221,413
DM
2020-06-19
NKNantkwest, Inc.Simon Barry J.See remarksS - Sale+OE$10.56-200,0413,170,540-6%-$2,112,950
2020-06-19
BCDABiocardia, Inc.Allen Jim L.DirP - Purchase$2.10+142,850668,384+27%+$299,985
2020-06-19
BCDABiocardia, Inc.Blank Andrew ScottDirP - Purchase$2.10+142,850269,523+113%+$299,985
2020-06-19
BCDABiocardia, Inc.Stertzer Simon HDir, 10%P - Purchase$2.10+142,8501,227,800+13%+$299,985
D
2020-06-22
ADPTAdaptive Biotechnologies CorpRobins Chad MCEO, COBS - Sale+OE$45.85-33,1321,778,180-2%-$1,519,227
D
2020-06-22
ADPTAdaptive Biotechnologies CorpHill Nancy LouiseEVP, Operations, Program ManaS - Sale+OE$45.22-19,00011,200-63%-$859,120
D
2020-06-19
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Business Development OffS - Sale+OE$45.00-4170-100%-$18,765
D
2020-06-22
ADVMAdverum Biotechnologies, Inc.Gasmi MehdiDirS - Sale+OE$25.06-23,605274,442-8%-$591,617
M
2020-06-19
DNLIDenali Therapeutics Inc.Bratton Douglas K10%S - Sale$24.72-255,00014,342,916-2%-$6,304,373
2020-06-19
VIRVir Biotechnology, Inc.Horn HowardCFOS - Sale$40.00-10,000257,777-4%-$400,000
D
2020-06-19
VIRVir Biotechnology, Inc.Virgin HerbertEVP, Research, CSOS - Sale+OE$38.00-3,5100-100%-$133,384
2020-06-19
LIFEAtyr Pharma IncBroadfoot Jill MarieCFOP - Purchase$4.22+1,8509,153+25%+$7,807
2020-06-19
LIFEAtyr Pharma IncShukla SanjayPres, CEOP - Purchase$4.27+6,0007,291+465%+$25,620
D
2020-06-22
BBIBrickell Biotech, Inc.Sklawer Andrew DCOO, SecretaryP - Purchase$0.00+13,04496,250+16%+$0
D
2020-06-22
BBIBrickell Biotech, Inc.McAvoy David R.GC, CCOP - Purchase$0.00+30,43559,357+105%+$0
D
2020-06-22
BBIBrickell Biotech, Inc.Chadha DeepakChief Research, Dev. OfficerP - Purchase$0.00+26,08746,717+126%+$0
D
2020-06-22
BBIBrickell Biotech, Inc.Brown Robert BusardCEOP - Purchase$0.00+86,957216,659+67%+$0
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top